US2002102701A1PendingUtilityA1
licD1
Priority: Feb 28, 1997Filed: Mar 29, 2001Published: Aug 1, 2002
Est. expiryFeb 28, 2017(expired)· nominal 20-yr term from priority
Inventors:Michael Arthur Lonetto
A61K 38/00C07K 2319/00A61P 31/04A61P 37/04C07K 14/3156A61K 39/00
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides 1icD1 polypeptides and polynucleotides encoding 1icD1 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing licD1 polypeptides to screen for antibacterial compounds.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An isolated polynucleotide comprising a polynucleotide having at least a 70% identity to a polynucleotide encoding a polypeptide comprising the amino acid sequence of SEQ ID NO:2.
2 . An isolated polynucleotide comprising a polynucleotide having at least a 70% identity to a polynucleotide encoding the same mature polypeptide expressed by the 1icD1 gene contained in the Streptococcus pneumoniae.
3 . An isolated polynucleotide comprising a polynucleotide encoding a polypeptide comprising an amino acid sequence which is at least 70% identical to the amino acid sequence of SEQ ID NO:2.
4 . An isolated polynucleotide that is complementary to the polynucleotide of claim 1
5 . The polynucleotide of claim 1 wherein the polynucleotide is DNA or RNA
6 . The polynucleotide of claim 1 comprising the nucleic acid sequence set forth in SEQ ID NO:1.
7 . The polynucleotide of claim 1 comprising nucleotide 1 to the stop codon which begins at nucleotide number 802 set forth in SEQ ID NO:1.
8 . The polynucleotide of claim 1 which encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:2.
9 . A vector comprising the polynucleotide of claim 1 .
10 . A host cell comprising the vector of claim 9 .
11 . A process for producing a polypeptide comprising: expressing from the host cell of claim 10 a polypeptide encoded by said DNA.
12 . A process for producing a 1icD1 polypeptide or fragment comprising culturing a host of claim 10 under conditions sufficient for the production of said polypeptide or fragment.
13 . A polypeptide comprising an amino acid sequence which is at least 70% identical to the amino acid sequence of SEQ ID NO:2.
14 . A polypeptide comprising an amino acid sequence as set forth in SEQ ID NO:2.
15 . An antibody against the polypeptide of claim 14 .
16 . An antagonist which inhibits the activity or expression of the polypeptide of claim 14 .
17 . A method for the treatment of an individual in need of 1icD1 polypeptide comprising: administering to the individual a therapeutically effective amount of the polypeptide of claim 14 .
18 . A method for the treatment of an individual having need to inhibit 1icD1 polypeptide comprising: administering to the individual a therapeutically effective amount of the antagonist of claim 16 .
19 . A process for diagnosing a disease related to expression or activity of the polypeptide of claim 14 in an individual comprising:
(a) determining a nucleic acid sequence encoding said polypeptide, and/or
(b) analyzing for the presence or amount of said polypeptide in a sample derived from the individual.
20 . A method for identifying compounds which interact with and inhibit or activate an activity of the polypeptide of claim 14 comprising:
contacting a composition comprising the polypeptide with the compound to be screened under conditions to permit interaction between the compound and the polypeptide to assess the interaction of a compound, such interaction being associated with a second component capable of providing a detectable signal in response to the interaction of the polypeptide with the compound;
and determining whether the compound interacts with and activates or inhibits an activity of the polypeptide by detecting the presence or absence of a signal generated from the interaction of the compound with the polypeptide.
21 . A method for inducing an immunological response in a mammal which comprises inoculating the mammal with 1icD1 polypeptide of claim 14 , or a fragment or variant thereof, adequate to produce antibody and/or T cell immune response to protect said animal from disease.
22 . A method of inducing immunological response in a mammal which comprises delivering a nucleic acid vector to direct expression of 1icD1 polypeptide of claim 14 , or fragment or a variant thereof, for expressing said 1icD1 polypeptide, or a fragment or a variant thereof in vivo in order to induce an immunological response to produce antibody and/or T cell immune response to protect said animal from disease.
23 . A computer readable medium having stored thereon a member selected from the group consisting of: a polynucleotide comprising the sequence of SEQ ID NO. 1 or 3; a polypeptide comprising the sequence of SEQ ID NO. 2 or 4; a set of polynucleotide sequences wherein at least one of said sequences comprises the sequence of SEQ ID NO. 1 or 3; a set of polypeptide sequences wherein at least one of said sequences comprises the sequence of SEQ ID NO. 2 or 4; a data set representing a polynucleotide sequence comprising the sequence of SEQ ID NO. 1 or 3; a data set representing a polynucleotide sequence encoding a polypeptide sequence comprising the sequence of SEQ ID NO. 2 or 4; a polynucleotide comprising the sequence of SEQ ID NO. 1; a polypeptide comprising the sequence of SEQ ID NO. 2; a set of polynucleotide sequences wherein at least one of said sequences comprises the sequence of SEQ ID NO. 1; a set of polypeptide sequences wherein at least one of said sequences comprises the sequence of SEQ ID NO. 2; a data set representing a polynucleotide sequence comprising the sequence of SEQ ID NO. 1; a data set representing a polynucleotide sequence encoding a polypeptide sequence comprising the sequence of SEQ ID NO. 2.
24 . A computer based method for performing homology identification, said method comprising the steps of providing a polynucleotide sequence comprising the sequence of SEQ ID NO. 1 in a computer readable medium; and comparing said polynucleotide sequence to at least one polynucleotide or polypeptide sequence to identify homology.
25 . A further embodiment of the invention provides a computer based method for polynucleotide assembly, said method comprising the steps of: providing a first polynucleotide sequence comprising the sequence of SEQ ID NO. 1 in a computer readable medium; and screening for at least one overlapping region between said first polynucleotide sequence and a second polynucleotide sequence.
26 . An isolated polynucleotide comprising a polynucleotide having at least a 70% identity to a polynucleotide encoding a polypeptide comprising the amino acid sequence of SEQ ID NO:4.
27 . An isolated polynucleotide comprising a polynucleotide having at least a 70% identity to the polynucleotide sequence of SEQ ID NO:3.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.